Viral Gene Transfer
Viral Gene Transfer - Related Videos
03:36
Production of Retroviral Particles for Gene Transfer
0 Views •
2026
Source: Zjablovskaja, P., et al., Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells. J. Vis. Exp. (2018)This video demonstrates the production of recombinant retroviral particles by transfecting human kidney-derived packaging cells, enabling stable gene delivery to target cells for downstream applications such as genetic modification, functional assays, or lineage differentiation studies.
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
0 Views •
Cited by 21 •
2011
A method of gene transfer for the treatment of ischemic heart failure is described using a swine model of myocardial infarction. Our simple and reproducible method enables us to readily evaluate the efficacy of various gene transfers with a very simple and reproducible way.
01:27
Horizontal Gene Transfer
0 Views •
2025
Horizontal gene transfer (HGT) is a process where genetic material moves between organisms within the same generation, unlike vertical gene transfer, which occurs from parent to offspring. HGT plays a crucial role in microbial evolution, adaptation, and survival, particularly in shared environments like the human gut.Mobile genetic elements such as plasmids, prophages, integrons, insertion sequences, and transposons facilitate this process. HGT occurs through three primary mechanisms:...
02:08
Viral Gene Delivery in the Mouse Heart for Evaluating Gene Effects on Heart Function
0 Views •
2026
Source: Lu, A., et al. Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk. J. Vis. Exp. (2022)The video demonstrates a method for ultrasound-guided intramyocardial injection of a recombinant viral vector in a mouse model. This technique enables targeted gene delivery to the heart for studying the effects of transgene expression on cardiac function.
06:10
Gene Transfer into Older Chicken Embryos by ex ovo Electroporation
0 Views •
Cited by 2 •
2012
A method of gene transfer into chicken embryos at later incubation stages (older than Hamburger and Hamilton stage (HH) 22) is described. This method overcomes disadvantages of in ovo electroporation applied to older chicken embryos and is a useful technique to study gene function and regulation at older developmental stages.
FAQs
Specificity begins when viral particles recognize receptors on a cell’s surface. This recognition influences whether the particles can enter that cell and deliver their genetic cargo. Vector tropism, meaning the preference for particular cell types, therefore helps determine the range of cells affected and is an important consideration when targeting gene expression or therapeutic effects.
The vector and its design influence the fate of delivered DNA or RNA after cellular entry. Cargo may remain separate from the cell’s genome, allowing gene expression without integration, or it may integrate into the genome. This distinction affects how long expression persists and helps researchers select an approach for a particular biological or therapeutic goal.
These variables can limit the performance of a viral gene transfer system in different ways. Cargo capacity constrains how much genetic material a vector can carry, while immune responses may influence how the cell or organism responds to the viral particles. The resulting duration of gene expression also affects whether the approach suits a temporary study or a longer-lasting intervention.
A conceptual workflow begins by selecting a virus or engineered viral vector whose receptor recognition and cargo characteristics fit the target cells. The particles then contact cells, enter through receptor-mediated recognition, and release DNA or RNA cargo. Researchers subsequently examine whether the cargo produces gene expression and how long that expression remains detectable.
For gene-function studies, delivered genetic material can support analysis of how gene expression affects cells. In vaccine development, the same general strategy can help introduce genetic instructions relevant to an immune-stimulating design. The usefulness of either application depends on successful cell entry, appropriate cargo delivery, and an expression pattern that can be evaluated.
Viral gene transfer can contribute to gene therapy for inherited disorders by delivering genetic material intended to address a genetic deficiency. Its therapeutic usefulness depends on reaching the relevant cells, accommodating the required cargo, and achieving an appropriate duration of expression. Vector design and the recipient’s immune response therefore remain central considerations when evaluating potential treatment outcomes.